Surface Plasmon Resonance biosensor analysis as a useful tool in FBDD

Drug Discovery Today: Technologies

Volumn 7, Issue 3, 2010, Pages

  Retra, Kim ^a   Irth, Hubertus ^a   Van Muijlwijk Koezen, Jacqueline E ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA SECRETASE 1; CARBONATE DEHYDRATASE II;

ARTICLE; BINDING AFFINITY; BIOSENSOR; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG RESEARCH; DRUG SOLUBILITY; DRUG TARGETING; KINETICS; STRUCTURE ACTIVITY RELATION; SURFACE PLASMON RESONANCE; THERMODYNAMICS;

EID: 78650747031     PISSN: 17406749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddtec.2010.11.012     Document Type: Review

References (23)

1. C.A. Lipinski Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 46 2001 3 26
2. M. Congreve A 'rule of three' for fragment-based lead discovery? Drug Discov. Today 8 2003 876 877
3. D.J. Maly Combinatorial target-guided ligand assembly: identification of potent subtype-selective c-Src inhibitors Proc. Natl. Acad. Sci. U. S. A. 97 2000 2419 2424
4. D.A. Erlanson Fragment-based drug discovery J. Med. Chem. 47 2004 3463 3482
5. A. Kuglstatter Tyramine fragment binding to BACE-1 Bioorg. Med. Chem. Lett. 18 2008 1304 1307
6. M.D. Hämäläinen Label-free primary screening and affinity ranking of fragment libraries using parallel analysis of protein panels J. Biomol. Screen. 13 2008 202 209
7. Geitmann, M., et al. Fragment screening using SPR biosensors: selection of hits for HIV-1 reverse transcriptase. Manuscript in preparation
8. S. Perspicace Fragment-based screening using surface plasmon resonance technology J. Biomol. Screen. 14 2009 337 349
9. I. Navratilova, and A.L. Hopkins Fragment screening by surface plasmon resonance ACS Med. Chem. Lett. 1 2010 44 48
10. R.L. Rich, and D.G. Myszka Kinetic analysis and fragment screening with Fujifilm AP-3000 Anal. Biochem. 402 2010 170 178
11. C. Kreatsoulas, and K. Narayan Algorithms for the automated selection of fragment-like molecules using single-point surface plasmon resonance measurements Anal. Biochem. 402 2010 179 184
12. M. Kobayashi Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification J. Biomol. Screen. 15 2010 978 989
13. H. Nordström Identification of MMP-12 inhibitors by using biosensor-based screening of a fragment library J. Med. Chem. 51 2008 3449 3459
14. T. Neumann Discovery of thrombin inhibitor fragments from chemical microarray screening Lett. Drug Des. Discov. 2 2007 563 566
15. T. Neumann SPR-based fragment screening: advantages and applications Curr. Top. Med. Chem. 7 2007 1630 1642
16. R.L. Rich Biosensor-based fragment screening using FastStep injections Anal. Biochem. 407 2010 270 277
17. P.D. Edwards Application of fragment-based lead generation to the discovery of novel, cyclic amidine beta-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency J. Med. Chem. 50 2007 5912 5925
18. S. Geschwindner Discovery of a novel warhead against beta-secretase through fragment-based lead generation J. Med. Chem. 50 2007 5903 5911
19. M. Nilsson Compounds binding to the S2-S3 pockets of thrombin J. Med. Chem. 52 2009 2708 2715
20. G.E. De Kloe Surface Plasmon Resonance biosensor based fragment screening using acetylcholine binding protein identifies ligand efficiency hot spots by deconstruction of nicotinic acetylcholine receptor alpha7 ligands J. Med. Chem. 53 2010 7192 7201
21. M. Geitmann Interaction kinetic and structural dynamic analysis of ligand binding to acetylcholine-binding protein Biochemistry 407 2010 58 64
22. Edink, E. et al. Fragment growing induces conformational changes in acetylcholine-binding protein: a structural and thermodynamic analysis. (submitted)
23. S.S. Antonysamy Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors Bioorg. Med. Chem. Lett. 18 2008 2990 2995